target?, page-13

The fundamentals still haven't really changed for me, I'm shocked at the spike yesterday/ this morning. I'd already assumed that a further CF study for 18 and over would have been factored into the SP. Thought it would of taking abit more than that to move the SP like that.( Need to see costs being cut, and significant improvements to revenues) I guess the 6 month duration instead of 12, was a key factor( With lower costs, and shorter time to marketing approval), the next price sensitive news will come from the business plan announcement on the 28th. It will be interesting to see the direction the company take in terms of $$ spend, and also if the trial can commence asap instead of early next year when the additional Novaquest funding becomes available,this could cause another spike. IMO

Pretty hard to go setting targets, but the first leg could be 0.27 where previous support now becomes resistance, and also around 0.32 around the prior all time lows.